Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 12Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Prostatic Neoplasms 4Solid Tumor 3Neoplasm Metastasis 3Melanoma 3Recurrence 2Pancreatic Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma 2Gastrointestinal Stromal Tumors 2Colonic Neoplasms 2Choledocholithiasis 2Carcinoma 2Advanced Solid Tumor 2cMET-dysregulated Advanced Solid Tumors 1Terminal Cancer 1Synovitis, Pigmented Villonodular 1Stomach Neoplasms 1Solid Tumours 1Solid Tumour 1Solid Tumors 1Skin Neoplasms 1Respiratory Aspiration 1Respiration Disorders 1Rectal Neoplasms 1Rare Diseases 1Prostate Cancer Patients 1

Interventions

Ropivacaine 6Anesthesia, General 6Analgesics, Opioid 6Morphine 5Acetaminophen 5Saline Solution 4Lidocaine 4Ketamine 4Fentanyl 4Sodium Chloride 3Dexmedetomidine 3Bupivacaine 3Anesthetics, Local 3Anesthesia, Local 3Acupuncture Therapy 3trimebutine 3-thiocarbamoylbenzenesulfonate 2parecoxib 2Transcutaneous Electric Nerve Stimulation 2Tramadol 2Therapeutics 2Tea 2Surveys and Questionnaires 2Propofol 2Oxycodone 2Magnesium Sulfate 2Levobupivacaine 2Control Groups 2ramosetron 1acetaminophen, codeine drug combination 1Varenicline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Agnosia × Midazolam × Clear all
NCT04597268 2023-01-10

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

National Cancer Institute, Egypt

Phase NA Completed
75 enrolled

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡